ADAP
Adaptimmune Therapeutics
ADAP
ADAP
64 hedge funds and large institutions have $27.7M invested in Adaptimmune Therapeutics in 2025 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 9 increasing their positions, 19 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
3% less funds holding
Funds holding: 66 → 64 (-2)
53% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 19
Holders
64
Holding in Top 10
1
Calls
$11K
Puts
–
Top Buyers
| 1 | +$492K | |
| 2 | +$363K | |
| 3 | +$192K | |
| 4 |
AC
Almitas Capital
Santa Monica,
California
|
+$26.1K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$19.2K |
Top Sellers
| 1 | -$309K | |
| 2 | -$228K | |
| 3 | -$206K | |
| 4 |
MAM
MPM Asset Management
Boston,
Massachusetts
|
-$126K |
| 5 |
MB
MPM BioImpact
Boston,
Massachusetts
|
-$116K |
